In a Nov. 21 note, he maintained a “Speculative Buy” rating and C$5.25 (US$4.00) target.

A New Hair Loss Treatment Backed by Google Ventures Might Finally Make Baldness a Thing of the Past ...

TG Therapeutics remains attractive for investors despite competition and slowing growth. Read the latest analysis on the stock here.

RA Capital Management’s Peter Kolchinsky says the companies that survived the industry’s 2021 rout are thriving—and looking ...

As we prepare to enter 2026, Okayplayer wraps up our 2025 with a list of the 25 songs that defined the year — a soundtrack of ...

Intellia Therapeutics pauses Nex-z gene-editing trial after participant death. Click here for my updated look at NTLA stock and why I am downgrading it.

Objective The objective of this study is to assess the association between childhood exposure to pets and farm animals and ...

Introduction The COVID-19 pandemic is expected to have impacted many drivers of antimicrobial resistance (AMR) and compounded ...

Major League Baseball and the Major League Baseball Players Association on Monday released the annual public report from the ...

To many NFL players, random drug tests from the league are an inconvenience that sometimes don't feel so random. To Denver Broncos linebacker Alex Singleton, it's something that he's glad happened to ...

Listen to new must-hear songs from emerging R&B/hip-hop artists like Lily Massie and SAHXL.

The global lateral flow assays market size is expected to reach USD 17.44 billion by 2033, registering a CAGR of 6.98% from 2025 to 2033, according to a new report by Grand View Research, Inc. The ...